These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 332054)

  • 41. Treatment of acromegaly with bromocriptine.
    Wang C; Chan V; Yeung RT
    Aust N Z J Med; 1979 Jun; 9(3):225-32. PubMed ID: 288387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
    Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Twin pregnancy following bromocriptine in an acromegalic patient staying sterile after removal of a pituitary adenoma. Immunocytochemical study of the tumor (author's transl)].
    Brun JM; Bloch B; Bugnon C; Putelat R
    Ann Endocrinol (Paris); 1979; 40(6):551-2. PubMed ID: 232833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Harris AG; Kvistborg A; Kjartansson O; Hanssen E; Smiseth O; Djøsland O; Hass G; Jervell J
    J Clin Endocrinol Metab; 1990 May; 70(5):1254-61. PubMed ID: 2186055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cabergoline treatment of acromegaly: a preliminary dose finding study.
    Jackson SN; Fowler J; Howlett TA
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):745-9. PubMed ID: 9274706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
    Mornex R; Berthezene F; Claustrat B; Fischer C
    Ann Endocrinol (Paris); 1976; 37(4):303-4. PubMed ID: 1037362
    [No Abstract]   [Full Text] [Related]  

  • 49. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
    Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
    J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
    Hanew K; Sugawara A; Shimizu Y; Sato S; Sasaki A; Tazawa S; Ishii K; Saitoh T; Saso S; Yoshinaga K
    Endocrinol Jpn; 1989 Jun; 36(3):429-38. PubMed ID: 2510991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
    Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
    Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.
    Verde G; Chiodini PG; Liuzzi A; Cozzi R; Favales F; Botalla L; Spelta B; Dalla Bonzana D; Rainer E; Horowski R
    J Endocrinol Invest; 1980; 3(4):405-14. PubMed ID: 6782153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly.
    Wass JA; Clemmons DR; Underwood LE; Barrow I; Besser GM; Van Wyk JJ
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):369-77. PubMed ID: 6890417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
    Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bromocriptine suppression of plasma growth hormone in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Results of treatment for acromegaly with long-acting bromocriptine (Parlodel LAR)].
    Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Bolanowski M; Jedrzejak J; Milewicz A
    Endokrynol Pol; 1993; 44(2):161-8. PubMed ID: 8055787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of acromegaly with decreased GH levels in the serum by the treatment of either metoclopramide or the combination with CB-154 (author's transl)].
    Naito T; Nakamura T; Suzuki H; Kasai K; Shiina H
    Horumon To Rinsho; 1980 Sep; 28(9):1026-30. PubMed ID: 7460352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.